Mutations in NDUFB11, Encoding a Complex I Component of the Mitochondrial Respiratory Chain, Cause Microphthalmia with Linear Skin Defects Syndrome

• Published in: American journal of human genetics Vol. 96; no. 4; pp. 640 - 650
• Main Authors: van Rahden, Vanessa A., Fernandez-Vizarra, Erika, Alawi, Malik, Brand, Kristina, Fellmann, Florence, Horn, Denise, Zeviani, Massimo, Kutsche, Kerstin
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 02.04.2015; Cell Press; Elsevier
• Subjects: Brain - pathology; Chromosomes; Codon, Nonsense - genetics; Congenital diseases; Electron Transport Complex I - genetics; Exome - genetics; Female; Gene Knockdown Techniques; Genetic Diseases, X-Linked - genetics; Genetic Diseases, X-Linked - pathology; Genetic disorders; Genomics; HeLa Cells; Humans; Immunohistochemistry; Karyotyping; Magnetic Resonance Imaging; Microphthalmos - genetics; Microphthalmos - pathology; Mitochondria; Mutation; Pedigree; Reverse Transcriptase Polymerase Chain Reaction; RNA-protein interactions; Skin Abnormalities - genetics; Skin Abnormalities - pathology; X Chromosome Inactivation - genetics
• ISSN: 0002-9297; 1537-6605
• DOI: 10.1016/j.ajhg.2015.02.002

Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject’s mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH:ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.